Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Healthcare affordability in America drops to lowest level since 2021

18

Jun 2026

Healthcare affordability in America drops to lowest level since 2021

New research released today from the West Health-Gallup Center on Healthcare in America finds that fewer than half of Americans (49%) are considered "Cost Secure," meaning they can consistently afford healthcare and prescription medications when and where they need them, the lowest level recorded since West Health and Gallup launched its Healthcare Affordability Index in 2021.

Legal system contact increases mental health risks for youth

18

Jun 2026

Legal system contact increases mental health risks for youth

Youth who have contact with the US legal system may be at increased risk of mental health symptoms including anxiety, depression, hostility, and psychoticism, according to a study published June 17, 2026 in the open access journal PLOS One by Raquel V. Oliveira and Elizabeth Culatta from Augusta University, US.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.